Literature DB >> 18566437

Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage.

Gary Chan1, Elizabeth R Bivins-Smith, M Shane Smith, Patrick M Smith, Andrew D Yurochko.   

Abstract

Monocytes are primary targets for human CMV (HCMV) infection and are proposed to be responsible for hematogenous dissemination of the virus. Monocytes acquire different functional traits during polarization to the classical proinflammatory M1 macrophage or the alternative antiinflammatory M2 macrophage. We hypothesized that HCMV induced a proinflammatory M1 macrophage following infection to promote viral dissemination because, biologically, a proinflammatory state provides the tools to drive infected monocytes from the blood into the tissue. To test this hypothesis of monocyte conversion from a normal quiescent phenotype to an inflammatory phenotype, we used Affymetrix Microarray to acquire a transcriptional profile of infected monocytes at a time point our data emphasized is a key temporal regulatory point following infection. We found that HCMV significantly up-regulated 583 (5.2%) of the total genes and down-regulated 621 (5.5%) of the total genes>or=1.5-fold at 4 h postinfection. Further ontology analysis revealed that genes implicated in classical M1 macrophage activation were stimulated by HCMV infection. We found that 65% of genes strictly associated with M1 polarization were up-regulated, while only 4% of genes solely associated with M2 polarization were up-regulated. Analysis of the monocyte chemokinome at the transcriptional level showed that 44% of M1 and 33% of M2 macrophage chemokines were up-regulated. Proteomic analysis using chemokine Ab arrays confirmed the secretion of these chemotactic proteins from HCMV-infected monocytes. Overall, the results identify that the HCMV-infected monocyte transcriptome displayed a unique M1/M2 polarization signature that was skewed toward the classical M1 activation phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566437      PMCID: PMC2614917          DOI: 10.4049/jimmunol.181.1.698

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

1.  Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.

Authors:  Damien Arnoult; Laura M Bartle; Anna Skaletskaya; Delphine Poncet; Naoufal Zamzami; Peter U Park; Juanita Sharpe; Richard J Youle; Victor S Goldmacher
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

2.  Locomotion of monocytes on endothelium is a critical step during extravasation.

Authors:  Alan R Schenkel; Zahra Mamdouh; William A Muller
Journal:  Nat Immunol       Date:  2004-03-14       Impact factor: 25.606

3.  Differential release of TNF-alpha, IL 1, and PGE2 by human blood monocytes subsequent to interaction with different bacterial derived agents.

Authors:  I J Fidler; A Nii; T Utsugi; D Brown; O Bakouche; E S Kleinerman
Journal:  Lymphokine Res       Date:  1990

4.  Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo.

Authors:  B W A van der Strate; J L Hillebrands; S S Lycklama à Nijeholt; L Beljaars; C A Bruggeman; M J A Van Luyn; J Rozing; T H The; D K F Meijer; G Molema; M C Harmsen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

7.  HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner.

Authors:  M Shane Smith; Gretchen L Bentz; Patrick M Smith; Elizabeth R Bivins; Andrew D Yurochko
Journal:  J Leukoc Biol       Date:  2004-04-23       Impact factor: 4.962

8.  Human cytomegalovirus-induced upregulation of intercellular cell adhesion molecule-1 on villous syncytiotrophoblasts.

Authors:  G Chan; M F Stinski; L J Guilbert
Journal:  Biol Reprod       Date:  2004-05-12       Impact factor: 4.285

Review 9.  MMP-1: the elder of the family.

Authors:  Annie Pardo; Moisés Selman
Journal:  Int J Biochem Cell Biol       Date:  2005-02       Impact factor: 5.085

10.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

View more
  98 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

3.  Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Authors:  Dan A Erkes; Guangwu Xu; Constantine Daskalakis; Katherine A Zurbach; Nicole A Wilski; Toktam Moghbeli; Ann B Hill; Christopher M Snyder
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

4.  PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes.

Authors:  Gary Chan; Maciej T Nogalski; Gretchen L Bentz; M Shane Smith; Alexander Parmater; Andrew D Yurochko
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

Review 5.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

6.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

7.  A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Authors:  Pranay Dogra; Mindy Miller-Kittrell; Elisabeth Pitt; Joseph W Jackson; Tom Masi; Courtney Copeland; Shuen Wu; William E Miller; Tim Sparer
Journal:  J Gen Virol       Date:  2016-09-13       Impact factor: 3.891

8.  STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.

Authors:  Nicole A Wilski; Colby Stotesbury; Christina Del Casale; Brian Montoya; Eric Wong; Luis J Sigal; Christopher M Snyder
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

9.  Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.

Authors:  Nicole A Wilski; Christina Del Casale; Timothy J Purwin; Andrew E Aplin; Christopher M Snyder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility.

Authors:  Gary Chan; Maciej T Nogalski; Andrew D Yurochko
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.